Open AccessPB2148: EFFICACY OF SMALL MOLECULE TARGET THERAPIES IN REFRACTORY OR RELAPSED DIFFUSE LARGE B‐CELL LYMPHOMA AND MOLECULAR SUBTYPING: A MULTI‐CENTER REAL‐WORLD EVIDENCE
Author(s) -
Zhang Y.,
Hou Y.,
Zhou X.,
Sun L.,
Wang W.,
Wo Y.,
Sun Y.,
Xu Q.,
Liu P.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000851420.29393.a1
Subject(s) - lenalidomide , ibrutinib , medicine , oncology , regimen , bruton's tyrosine kinase , diffuse large b cell lymphoma , cancer research , salvage therapy , lymphoma , chemotherapy , tyrosine kinase , leukemia , multiple myeloma , chronic lymphocytic leukemia , receptor